Results
1 -
10 of
10Managing Diabetic Nephropathies in Clinical Practice: Emerging and Future Therapies, Managing Diabetic Nephropathies in Clinical Practice Development of Efficient Routes to Access C-Glycosides as SGLT-2 Inhibitors for the Treatment of Type 2 Diabetes, Synthesis of Heterocycles in Contemporary Medicinal Chemistry Using SGLT2 Inhibitors in Special Populations, Essentials of SGLT2 Inhibitors in Diabetes Sotagliflozin bei Diabetes mellitus Typ??1, Der Diabetologe A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?, Indian Journal of Clinical Biochemistry Ein interessanter additiver Therapieansatz bei Typ-1-Diabetes, Info Diabetologie Sotagliflozin u2014 potenzielle Option zur Therapie des Typ-1-Diabetes, MMW - Fortschritte der Medizin The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus, Drugs SGLT-Hemmung bei Typ-1-Diabetes quo vadis?, Info Diabetologie SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice, Diabetes Therapy